Agilent Technologies Inc. and Burning Rock today announced they have signed an agreement under which Burning Rock will develop cancer diagnostics in China based on the Agilent SureSelect target enrichment system. Agilent is the leading provider of target enrichment for next-generation DNA s ... more
Agilent Technologies Opens Global Manufacturing Facility for Life Sciences Instruments
Agilent Technologies Inc. announced the opening of its new life sciences instruments manufacturing facility in Singapore. The facility will produce the company’s Liquid Chromatography/Mass Spectrometry (LC/MS) instruments for the global market.
“The opening of the LC/MS manufacturing facility marks a milestone in Agilent’s continued investment in Singapore, which began in 1970,” said Bill Sullivan, Agilent president and CEO. “Singapore is the ideal location for this facility as it will provide us with greater access to the life sciences instrument market in Asia. The new facility also will bring us closer to our customers, as the pharmaceutical and biopharmaceutical industries have become an important part of Singapore’s overall economy and investment strategy.”
The Agilent LC/MS facility is located within the Agilent Life Sciences Group Order Fulfillment Center, located at its Yishun, Singapore, site. The center will be responsible for efficient management of the supply-chain network -- including planning, procurement, value-added engineering and logistics. The center ensures that the LC/MS facility is able to efficiently and effectively deliver configurable solutions to customers worldwide while maintaining Agilent’s hallmark of quality.
Agilent Technologies Inc. introduced OneSight, a new software platform designed to help researchers visualize and analyze chromosomal aneuploidies in cell-free DNA sequencing data. Agilent unveiled its new bioinformatics product at the annual meeting of the American College of Medical Genet ... more
Agilent Technologies Inc. announced that the Chinese American Chromatography Association has honored Xiaoli Wang, Ph.D., with its Young Investigator Award. Dr. Wang is an Agilent scientist who has been instrumental in extending the company’s Poroshell 120 technology into biopharmaceutical c ... more
- 1Mysteries of enzyme mechanism revealed
- 2Breaking new territory analyzing DNA modifications in glioblastoma
- 3New method for analyzing crystal structure
- 4How good is the measurement method?
- 5ZEISS and EPFL begin long-term research collaboration
- 6Enough is enough
- 7A new record at BESSY II: ten million ions in an ion trap cooled for the first time to 7.4 K